Skip to main content
SpringerLink
Log in

Clinical Significance of Occult Metastatic Melanoma in Sentinel Lymph Nodes and Other High-risk Factors Based on Long-term Follow-up

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Selective sentinel lymphadenectomy (SSL) following preoperative lymphoscintigraphy is the most significant recent advance in the management of patients with primary melanoma. This study evaluates the prognostic value of sentinel lymph node (SLN) status and other risk factors in predicting survival and recurrence in patients with primary cutaneous melanoma. From October 1993 to July 1998 a series of 412 patients with primary invasive melanoma underwent SSL at the UCSF/ Mt. Zion Melanoma Center. The outcome of 363 evaluable patients is summarized in this study. The factors related to survival and disease recurrence were analyzed by Cox proportional hazard regression models. The overall incidence of patients with positive SLNs was 18%. Over a median follow-up of 4.8 years, the overall mortality rate in patients with primary cutaneous melanoma was 18.7%, and 74 recurrences occurred (20.4%). Mortality was significantly related to SLN status [HR = 2.06; 95% Confidence interval (CI) 1.18, 3.58], angiolymphatic invasion (HR = 2.21; 95% CI 1.08, 4.55), ulceration (HR = 1.79; 95% CI 1.02, 3.15), mitotic index (HR =1.38; 95% CI 1.01, 1.90), and tumor thickness (HR = 2.20, 95% CI 1.21, 3.99). Factors significantly related to disease-free survival included SLN status (HR = 2.09; 95% CI 1.31, 3.34), tumor thickness (HR = 1.89; 95%. CI 1.20,2.98), and age (HR= 1.26 95% CI 1.08, 1.47). SLN status was the most significant factor for melanoma recurrence and death. Other important predictors include tumor thickness, ulceration, lymphatic invasion, and mitotic index.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. DL Morton DR Wen JH Wong et al. (1992) ArticleTitleTechnical details of intraoperative lymphatic mapping for early stage melanoma Arch. Surg. 9:127 392

    Google Scholar 

  2. DS Reintgen CW Cruse K Wells (1994) ArticleTitleThe orderly progression of melanoma nodal metastases Ann. Surg. 67 759–767

    Google Scholar 

  3. JJ Albertini CW Cruse D Rapaport et al. (1996) ArticleTitleIntraoperative radio-lympho-scintigraphy improves sentinel lymph node identification for patients with melanoma Ann. Surg. 223 217–224 Occurrence Handle10.1097/00000658-199602000-00016 Occurrence Handle8597518

    Article  PubMed  Google Scholar 

  4. DN Krag SJ Meijer DL Weaver et al. (1995) ArticleTitleMinimal-access surgery for staging of malignant melanoma Arch. Surg. 8 654–658

    Google Scholar 

  5. MI Ross DS Reintgen CM Balch (1993) ArticleTitleSelective lymphadenectomy: emerging role for lymphatic mapping and sentinel node biopsy in the management of early stage melanoma Semin. Surg. Oncol. 9 219–223 Occurrence Handle8516607

    PubMed  Google Scholar 

  6. JF Thompson WH McCarthy CM Bosch et al. (1995) ArticleTitleSentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes Melanoma Res. 5 255–260 Occurrence Handle7496161

    PubMed  Google Scholar 

  7. DL Morton AD Chan (1999) ArticleTitleCurrent status of intraoperative lymphatic mapping and sentinel lymphadenectomy for melanoma: is it standard of care? J. Am. Coll. Surg. 189 214–223 Occurrence Handle10.1016/S1072-7515(99)00129-5 Occurrence Handle10437845

    Article  PubMed  Google Scholar 

  8. SPL Leong (2004) ArticleTitleSentinel lymph node mapping and selective lymphadenectomy: the standard of care for melanoma Curr. Treat. Options Oncol. 5 185–194 Occurrence Handle15115647

    PubMed  Google Scholar 

  9. J Norman C Cruse C Espinosa et al. (1991) ArticleTitleRedefinition of cutaneous lymphatic drainage with the use of lymphoscintigraphy for malignant melanoma Am. J. Surg. 162 432–437 Occurrence Handle10.1016/0002-9610(91)90255-C Occurrence Handle1951904

    Article  PubMed  Google Scholar 

  10. J Thompson R Uren H Shaw et al. (1999) ArticleTitleLocation of sentinel lymph nodes in patients with cutaneous melanoma: new insights into lymphatic anatomy J. Am. Coll. Surg. 189 195–206 Occurrence Handle10.1016/S1072-7515(99)00108-8 Occurrence Handle10437842

    Article  PubMed  Google Scholar 

  11. SPL Leong TA Achtem FA Habib et al. (1999) ArticleTitleDiscordancy between clinical predictions versus lymphoscintigraphic and intraoperative mapping of sentinel lymph node drainage of primary melanoma Arch. Dermatol. 135 1472–1476 Occurrence Handle10.1001/archderm.135.12.1472 Occurrence Handle10606052

    Article  PubMed  Google Scholar 

  12. KM McMasters SL Wong MJ Edwards et al. (2001) ArticleTitleFactors that predict the presence of sentinel lymph node metastasis in patients with melanoma Surgery 130 151–156 Occurrence Handle10.1067/msy.2001.115830 Occurrence Handle11490343

    Article  PubMed  Google Scholar 

  13. BS Cherpelis F Haddad J Messina et al. (2001) ArticleTitleSentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas J. Am. Acad. Dermatol. 44 762–766 Occurrence Handle10.1067/mjd.2001.112346 Occurrence Handle11312421

    Article  PubMed  Google Scholar 

  14. JE Gershenwald W Thompson PF Mansfield et al. (1999) ArticleTitleMulti-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients J. Clin. Oncol. 17 976–983 Occurrence Handle10071292

    PubMed  Google Scholar 

  15. MG Statius Muller PA Leeuwen Particlevan ES Lange-De Klerk Particlede et al. (2001) ArticleTitleThe sentinel lymph node status is an important factor for predicting clinical outcome in patients with stage I or II cutaneous melanoma Cancer 91 2401–2408 Occurrence Handle10.1002/1097-0142(20010615)91:12<2401::AID-CNCR1274>3.0.CO;2-I Occurrence Handle11413531

    Article  PubMed  Google Scholar 

  16. BM Clary B Mann MS Brady et al. (2001) ArticleTitleEarly recurrence after lymphatic mapping and sentinel node biopsy in patients with primary extremity melanoma: a comparison with elective lymph node dissection Ann-Surg.Oncol. 8 328–337 Occurrence Handle11352306

    PubMed  Google Scholar 

  17. R Essner A Conforti MC Kelley et al. (1999) ArticleTitleEfficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma Ann. Surg. Oncol. 6 442–449 Occurrence Handle10.1007/s10434-999-0442-4 Occurrence Handle10458681

    Article  PubMed  Google Scholar 

  18. MA Gadd AB Cosimi J Yu et al. (1999) ArticleTitleOutcome of patients with melanoma and histologically negative sentinel lymph nodes Arch. Surg. 134 381–387 Occurrence Handle10.1001/archsurg.134.4.381 Occurrence Handle10199310

    Article  PubMed  Google Scholar 

  19. K Sondergaard (1985) ArticleTitleDepth of invasion and tumor thickness in primary cutaneous malignant melanoma: a study of 2012 cases Acta Pathol Microbiol. Immunol. Scand. [A] 93 49–55

    Google Scholar 

  20. CM Balch TM Murad S-J Soong et al. (1978) ArticleTitleA multifactorial analysis of melanoma: prognostic histopathologic features comparing Clark’s and Breslow’s staging methods Ann. Surg. 188 732–742 Occurrence Handle736651

    PubMed  Google Scholar 

  21. CM Balch S-J Soong TM Murad et al. (1979) ArticleTitleA multifactorial analysis of melanoma. II. Prognostic factors in patients with stage I (localized) melanoma Surgery 86 343 Occurrence Handle462379

    PubMed  Google Scholar 

  22. AC Buzaid MI Ross CM Balch et al. (1977) ArticleTitleCritical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system J. Clin. Oncol. 15 1039–1051

    Google Scholar 

  23. DL Morton DG Davtyan LA Wanek et al. (1993) ArticleTitleMultivariate analysis of the relationship between survival and the microstage of primary melanoma by Clark level and Breslow thickness Cancer 71 3737–3743 Occurrence Handle8490924

    PubMed  Google Scholar 

  24. S Mraz-Gernhard RW Sagebiel M Kashani-Sabet et al. (1998) ArticleTitlePrediction of sentinel lymph node micrometastasis by histological features in primary cutaneous malignant melanoma Arch. Dermatol. 134 983–987 Occurrence Handle10.1001/archderm.134.8.983 Occurrence Handle9722728

    Article  PubMed  Google Scholar 

  25. SPL Leong I Steinmetz F Habib et al. (1997) ArticleTitleOptimal selective sentinel lymph node dissection in primary malignant melanoma Arch. Surg. 132 666–673 Occurrence Handle9197861

    PubMed  Google Scholar 

  26. PA Treseler PS Tauchi (2000) ArticleTitlePathologic analysis of the sentinel lymph node Surg. Clin North Am. 80 1695–1719 Occurrence Handle10.1016/S0039-6109(05)70256-5 Occurrence Handle11140868

    Article  PubMed  Google Scholar 

  27. CM Balch AC Buzaid S Soong et al. (2001) ArticleTitleFinal version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma J. Clin. Oncol. 19 3535–3648

    Google Scholar 

  28. JD Wagner J Ranieri DZ Evdokimow et al. (2003) ArticleTitlePatterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphodenectomy for melanoma Plast. Reconstr. Surg. 12 486–497 Occurrence Handle10.1097/01.PRS.0000070989.23469.1F

    Article  Google Scholar 

  29. Leong SPL, Kashani-Sabet M, Desmond RA, et al. Clinical significance of occult metastatic melanoma to sentinel lymph nodes and other high risk factors based on a long-term follow-up. World J. Surg. 2005;29:in press

  30. DG Coit A Rogatko MF Brennan (1991) ArticleTitlePrognostic factors in patients with melanoma metastatic to axillary or inguinal lymph nodes: a multivariate analysis Ann. Surg. 214 627–636 Occurrence Handle1953117

    PubMed  Google Scholar 

  31. CL Day RA Lew MC Mihm et al. (1981) ArticleTitleThe natural break points for primary-tumor thickness in clinical stage I melanoma N. Engl. J. Med. 305 1155

    Google Scholar 

  32. CP Karakousis LJ Emrich U Rao (1989) ArticleTitleTumor thickness and prognosis in clinical stage I malignant melanoma Cancer 64 1432–1436 Occurrence Handle2776106

    PubMed  Google Scholar 

  33. M Kashani-Sabet RW Sagebiel CM Ferreira et al. (2001) ArticleTitleVascular involvement in the prognosis of primary cutaneous melanoma Arch. Dermatol. 137 1169–1173 Occurrence Handle11559212

    PubMed  Google Scholar 

  34. JE Gershenwald MI Colome JE Lee et al. (1998) ArticleTitlePatterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma J. Clin. Oncol. 16 2253–2260 Occurrence Handle9626228

    PubMed  Google Scholar 

  35. M Robert D Wen A Cochran (1993) ArticleTitlePathological evaluation of the regional lymph nodes in malignant melanoma Semin. Diagn. Pathol. 10 102–115 Occurrence Handle8506413

    PubMed  Google Scholar 

  36. JL Messina LF Glass (1997) ArticleTitlePathologic examination of the sentinel lymph node J. Fla. Med. Assoc. 84 153–156 Occurrence Handle9143165

    PubMed  Google Scholar 

  37. R Heller J Becker J Wasselle et al. (1992) ArticleTitleDetection of occult lymph node metastases in malignant melanoma Ann. Plast. Surg. 28 74–77 Occurrence Handle1642412

    PubMed  Google Scholar 

  38. X Wang R Heller N VanVoorheis et al. (1994) ArticleTitleDetection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma Ann. Surg. 220 768–774 Occurrence Handle7986144

    PubMed  Google Scholar 

  39. SC Shivers X Wang W Li et al. (1998) ArticleTitleMolecular staging of malignant melanoma: correlation with clinical outcome J.A.M.A. 280 1410–1415 Occurrence Handle9801000

    PubMed  Google Scholar 

  40. KF Carson DR Wen PX Li et al. (1996) ArticleTitleNodal nevi and cutaneous melanomas Am. J. Surg. Pathol. 20 834–840 Occurrence Handle10.1097/00000478-199607000-00006 Occurrence Handle8669531

    Article  PubMed  Google Scholar 

  41. DA Biddle (2003) ArticleTitleIntraparenchymal nevus cell aggregates in lymph nodes: a possible diagnostic pitfall with malignant melanoma and carcinoma Am. J. Surg. Pathol. 27 673–681 Occurrence Handle10.1097/00000478-200305000-00011 Occurrence Handle12717252

    Article  PubMed  Google Scholar 

  42. P Bostick DL Morton RR Turner et al. (1999) ArticleTitlePrognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients J. Clin. Oncol. 17 3238–3244 Occurrence Handle10506625

    PubMed  Google Scholar 

  43. DL Morton DS Hoon AJ Cochran et al. (2003) ArticleTitleLymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases Ann. Surg. 238 538–550 Occurrence Handle14530725

    PubMed  Google Scholar 

  44. H Takeuchi DL Morton C Kuo et al. (2004) ArticleTitlePrognostic significance of molecular upstaging of paraffin-embedded sentinel lymph nodes in melanoma patients J. Clin. Oncol. 22 2671–2680 Occurrence Handle10.1200/JCO.2004.12.009 Occurrence Handle15226334

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported in part by the Eva B. Buck Charitable Trust and the UCSF/Mount Zion Auxiliary Fund.

Author information

Authors and Affiliations

  1. Department of Surgery, University of California, San Francisco, Medical Center at Mount Zion and CSF Comprehensive Cancer Center, 1600 Divisadero Street, Box 1674, San Francisco, California 94143, USA

    Stanley P.L. Leong M.D., Robert P. Kim M.D., Dennis H. Nguyen B.A., Kensho Iwanaga B.A. & Robert E. Allen Jr. M.D.

  2. Department of Dermatology, University of California, San Francisco, Medical Center at Mount Zion and CSF Comprehensive Cancer Center, 1600 Divisadero Street, San Francisco, California 94143, USA

    Mohammed Kashani-Sabet M.D. & Richard W. Sagebiel M.D.

  3. Medical Statistics Section, University of Alabama at Birmingham Comprehensive Cancer Center, 1802 6th Avenue South, NP 2540, Birmingham, Alabama 35294, USA

    Renee A. Desmond Ph.D., Yuting Zhang M.S. & Seng-Jaw Soong Ph.D.

  4. Department of Pathology, University of California, San Francisco, Medical Center at Mount Zion and CSF Comprehensive Cancer Center, 1600 Divisadero Street, San Francisco, California 94143, USA

    Patrick A. Treseler M.D., Ph.D.

  5. Department of Nuclear Medicine, University of California, San Francisco, Medical Center at Mount Zion and CSF Comprehensive Cancer Center, 1600 Divisadero Street, San Francisco, California 94143, USA

    Eugene T. Morita M.D.

Authors
  1. Stanley P.L. Leong M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mohammed Kashani-Sabet M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Renee A. Desmond Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Robert P. Kim M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Dennis H. Nguyen B.A.
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kensho Iwanaga B.A.
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Patrick A. Treseler M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Robert E. Allen Jr. M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Eugene T. Morita M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Yuting Zhang M.S.
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Richard W. Sagebiel M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Seng-Jaw Soong Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stanley P.L. Leong M.D..

Rights and permissions

Reprints and permissions

About this article

Cite this article

Leong, S.P., Kashani-Sabet, M., Desmond, R.A. et al. Clinical Significance of Occult Metastatic Melanoma in Sentinel Lymph Nodes and Other High-risk Factors Based on Long-term Follow-up. World J. Surg. 29, 683–691 (2005). https://doi.org/10.1007/s00268-005-7736-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-005-7736-x

Keywords

Search

Navigation